422 related articles for article (PubMed ID: 17953828)
1. [A follow-up study about 52 cases of atypical lobular hyperplasia and lobular carcinoma in situ of the breast].
Li HY; Ren GS; Arnould N; Brettes JP
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):874-6. PubMed ID: 17953828
[TBL] [Abstract][Full Text] [Related]
2. Surgical outcome of biopsy-proven lobular neoplasia: is there any difference between lobular carcinoma in situ and atypical lobular hyperplasia?
Ibrahim N; Bessissow A; Lalonde L; Mesurolle B; Trop I; Lisbona A; El-Khoury M
AJR Am J Roentgenol; 2012 Feb; 198(2):288-91. PubMed ID: 22268170
[TBL] [Abstract][Full Text] [Related]
3. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
4. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
[TBL] [Abstract][Full Text] [Related]
6. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy.
Berg WA; Mrose HE; Ioffe OB
Radiology; 2001 Feb; 218(2):503-9. PubMed ID: 11161169
[TBL] [Abstract][Full Text] [Related]
7. Correlation between core biopsy and excisional biopsy in breast high-risk lesions.
Margenthaler JA; Duke D; Monsees BS; Barton PT; Clark C; Dietz JR
Am J Surg; 2006 Oct; 192(4):534-7. PubMed ID: 16978969
[TBL] [Abstract][Full Text] [Related]
8. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
[TBL] [Abstract][Full Text] [Related]
9. Lobular neoplasia on core needle biopsy does not require excision.
Nagi CS; O'Donnell JE; Tismenetsky M; Bleiweiss IJ; Jaffer SM
Cancer; 2008 May; 112(10):2152-8. PubMed ID: 18348299
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy.
Shah-Khan MG; Geiger XJ; Reynolds C; Jakub JW; Deperi ER; Glazebrook KN
Ann Surg Oncol; 2012 Oct; 19(10):3131-8. PubMed ID: 22847124
[TBL] [Abstract][Full Text] [Related]
11. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.
Elsheikh TM; Silverman JF
Am J Surg Pathol; 2005 Apr; 29(4):534-43. PubMed ID: 15767810
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of lobular neoplasia on breast core biopsy.
Karabakhtsian RG; Johnson R; Sumkin J; Dabbs DJ
Am J Surg Pathol; 2007 May; 31(5):717-23. PubMed ID: 17460455
[TBL] [Abstract][Full Text] [Related]
13. Lobular carcinoma in situ/atypical lobular hyperplasia on breast needle biopsies: does it warrant surgical excisional biopsy? A study of 27 cases.
O'Neil M; Madan R; Tawfik OW; Thomas PA; Fan F
Ann Diagn Pathol; 2010 Aug; 14(4):251-5. PubMed ID: 20637429
[TBL] [Abstract][Full Text] [Related]
14. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy.
Shin SJ; Rosen PP
Arch Pathol Lab Med; 2002 Jun; 126(6):697-701. PubMed ID: 12033958
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk factors in younger and older women.
Chun J; Pocock B; Joseph KA; El-Tamer M; Klein L; Schnabel F
Ann Surg Oncol; 2009 Jan; 16(1):96-9. PubMed ID: 18979140
[TBL] [Abstract][Full Text] [Related]
16. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
Port ER; Park A; Borgen PI; Morris E; Montgomery LL
Ann Surg Oncol; 2007 Mar; 14(3):1051-7. PubMed ID: 17206485
[TBL] [Abstract][Full Text] [Related]
17. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
Jolly S; Kestin LL; Goldstein NS; Vicini FA
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
[TBL] [Abstract][Full Text] [Related]
18. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ.
Fisher ER; Costantino J; Fisher B; Palekar AS; Paik SM; Suarez CM; Wolmark N
Cancer; 1996 Oct; 78(7):1403-16. PubMed ID: 8839545
[TBL] [Abstract][Full Text] [Related]
19. Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ.
Ringberg A; Palmer B; Linell F; Rychterova V; Ljungberg O
Eur J Surg Oncol; 1991 Feb; 17(1):20-9. PubMed ID: 1847343
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast.
Goldstein NS; Kestin LL; Vicini FA
Cancer; 2001 Aug; 92(4):738-47. PubMed ID: 11550142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
